31 related articles for article (PubMed ID: 23106285)
1. QSAR analysis of 2-amino or 2-methyl-1-substituted benzimidazoles against Pseudomonas aeruginosa.
Podunavac-Kuzmanović SO; Cvetković DD; Barna DJ
Int J Mol Sci; 2009 Apr; 10(4):1670-1682. PubMed ID: 19468332
[TBL] [Abstract][Full Text] [Related]
2. QSAR Study of 17β-HSD3 Inhibitors by Genetic Algorithm-Support Vector Machine as a Target Receptor for the Treatment of Prostate Cancer.
Pourbasheer E; Vahdani S; Malekzadeh D; Aalizadeh R; Ebadi A
Iran J Pharm Res; 2017; 16(3):966-980. PubMed ID: 29201087
[TBL] [Abstract][Full Text] [Related]
3. QSAR Analysis for Some 1, 2-Benzisothiazol-3-one Derivatives as Caspase-3 Inhibitors by Stepwise MLR Method.
Hajimahdi Z; Safizadeh F; Zarghi A
Iran J Pharm Res; 2016; 15(2):439-48. PubMed ID: 27642314
[TBL] [Abstract][Full Text] [Related]
4. R software for QSAR analysis in phytopharmacological studies.
Ningthoujam SS; Nath R; Kityania S; Mazumder PB; Dutta Choudhury M; Talukdar AD; Nahar L; Sarker SD
Phytochem Anal; 2023 Oct; 34(7):709-728. PubMed ID: 37392081
[TBL] [Abstract][Full Text] [Related]
5. Experimentally Validated QSAR Model for Surface p
Dhumal DM; Patil PD; Kulkarni RV; Akamanchi KG
ACS Omega; 2020 Dec; 5(49):32023-32031. PubMed ID: 33344856
[TBL] [Abstract][Full Text] [Related]
6. Targeting the C-Terminal Domain Small Phosphatase 1.
Rallabandi HR; Ganesan P; Kim YJ
Life (Basel); 2020 May; 10(5):. PubMed ID: 32397221
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016).
Vanangamudi M; Poongavanam V; Namasivayam V
Curr Med Chem; 2017 Nov; 24(34):3774-3812. PubMed ID: 28685686
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry.
Bastos MM; Costa CCP; Bezerra TC; da Silva FC; Boechat N
Eur J Med Chem; 2016 Jan; 108():455-465. PubMed ID: 26708112
[TBL] [Abstract][Full Text] [Related]
9. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
10. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Lagos CF; Caballero J; Gonzalez-Nilo FD; David Pessoa-Mahana C; Perez-Acle T
Chem Biol Drug Des; 2008 Nov; 72(5):360-9. PubMed ID: 19012572
[TBL] [Abstract][Full Text] [Related]
11. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
[TBL] [Abstract][Full Text] [Related]
12. QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Duchowicz PR; Fernández M; Caballero J; Castro EA; Fernández FM
Bioorg Med Chem; 2006 Sep; 14(17):5876-89. PubMed ID: 16766190
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
San Juan AA
Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
[TBL] [Abstract][Full Text] [Related]
14. Variable selection based QSAR modeling on Bisphenylbenzimidazole as Inhibitor of HIV-1 reverse transcriptase.
Kumar S; Tiwari M
Med Chem; 2013 Nov; 9(7):955-67. PubMed ID: 23106285
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
